Adapta
Device Pacemakers
PDI 00643169441873
General payments
$50,891
Research payments
$242,361
Through program year 2025, $50,891 in general payments and $242,361 in research payments were reported against Adapta (Pacemakers).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
10 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $546 | 15 |
| 2025 | Research | $89,764 | 45 |
| 2024 | General | $5,592 | 157 |
| 2024 | Research | $102,660 | 34 |
| 2023 | General | $10,234 | 372 |
| 2023 | Research | $27,422 | 17 |
| 2022 | General | $15,481 | 171 |
| 2022 | Research | $1,053 | 2 |
| 2021 | General | $19,037 | 204 |
| 2021 | Research | $21,463 | 11 |
Breakdown
The top 5 of 14 recipients; each share is of general payments naming this product in 2025.
The top 5 of 7 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
Each share is of general payments naming this product in 2025 where a state was reported.
Records
919 general · 109 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.